1
Total investments
0
Early stage
0
Mid stage
0
Late stage
5y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Dec 2021
Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research.
Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology.
Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique Hôpitaux de Paris and INSERM protecting the Rarecells® Device and its consumables, as well as the analyses performed on cells isolated using the Rarecells® System.
Rarecells® Diagnostics is a science-driven company. We are scientists working for scientists and patients. We care about bringing benefits to the patients.The team delivers customer satisfaction by manufacturing high quality products and providing high-level scientific assistance.
Rarecells® and ISET® are registered trademarks of Rarecells SAS.
Experience · 3 entries
All (3)
Investments (1)
2021
Investor
Dec 2021
Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research.
Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology.
Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique Hôpitaux de Paris and INSERM protecting the Rarecells® Device and its consumables, as well as the analyses performed on cells isolated using the Rarecells® System.
Rarecells® Diagnostics is a science-driven company. We are scientists working for scientists and patients. We care about bringing benefits to the patients.The team delivers customer satisfaction by manufacturing high quality products and providing high-level scientific assistance.
Rarecells® and ISET® are registered trademarks of Rarecells SAS.
Managing Partner
Nov 2021
We extend our partners capabilities, backing their business development, partneship and fundraising operations.
2020
Partner - Healthcare
Mar 2020
Care Finance, partenaire de vos projets financiers
- Votre entreprise a besoin de croître, innover, se développer.
- Vous avez un projet de cession ou de croissance externe.
Care Finance vous accompagne dans toutes ces étapes clefs de la vie de votre entreprise vous permettant de vous concentrer sur lessentiel
Startups ou PMEs, nous prenons le temps de vous accompagner dans la gestion financière de votre entreprise et de vous apporter des solutions personnalisées vos projets de financement, de transmission ou d’acquisition.
